Erratum to: Patient costs of breast cancer endocrine therapy agents under Medicare Part D vs with generic formulations. Springerplus 2015;4:531
Date
09/29/2015Pubmed ID
26413437Pubmed Central ID
PMC4577495DOI
10.1186/s40064-015-1233-yScopus ID
2-s2.0-84942305610 (requires institutional sign-in at Scopus site)Abstract
[This corrects the article DOI: 10.1186/s40064-015-0827-8.].
Author List
Nattinger AB, Pezzin LE, McGinley EL, Charlson JA, Yen TW, Neuner JMAuthors
John A. Charlson MD Associate Professor in the Medicine department at Medical College of WisconsinEmily L. McGinley MS, MPH Biostatistician III in the Center for Advancing Population Science department at Medical College of Wisconsin
Ann B. Nattinger MPH, MD Vice Dean, Associate Provost, Professor in the Medicine department at Medical College of Wisconsin
Liliana Pezzin PhD, MS, JD Director, Professor in the Institute for Health and Humanity department at Medical College of Wisconsin
Tina W F Yen BA, MS, MD Professor in the Surgery department at Medical College of Wisconsin
